Close Menu

NEW YORK (GenomeWeb) – Maravai LifeSciences said today that it has completed a new debt financing that will lower the interest rate on its existing debt and provide the company with an additional $50 million in capital.

Maravai, based in San Diego, said it will use the new funds to support growth in its three life science segments: bioprocess impurity testing, oligonucleotide synthesis, and protein detection.

JP Morgan led the debt financing along with Antares Capital and Carlyle Global Credit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.